Evergreen Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
+200
New +$204K ﹤0.01% 1359

Other funds holding LLY

Evergreen Capital Management's LLY Position: Q2 2026 in Review

Evergreen Capital Management reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $3.95M and leaving 12,152 shares worth $14.6M. The position accounts for 0.26% of the portfolio, ranked #87.

Evergreen Capital Management first reported a position in LLY in Q2 2018 and has held it in 33 quarters since. The position peaked at $14.7M in Q1 2026. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Evergreen Capital Management held 12,152 shares of Eli Lilly worth $14.6M as of Q2 2026.
  • Evergreen Capital Management sold 3,868 Eli Lilly shares in Q2 2026, an estimated $3.95M.
  • Eli Lilly made up 0.26% of Evergreen Capital Management's portfolio in Q2 2026, its #87 holding.
  • Evergreen Capital Management first reported a position in Eli Lilly in Q2 2018 and has held it in 33 quarters since.
  • Evergreen Capital Management's Eli Lilly position peaked at $14.7M in Q1 2026.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.